prostaglandins F, synthetic

Preferred Label : prostaglandins F, synthetic;

MeSH definition : Analogs or derivatives of prostaglandins F that do not occur naturally in the body. They do not include the product of the chemical synthesis of hormonal PGF.;

MeSH synonym : synthetic, pgf; synthetic prostaglandins f; pgf synthetic; prostaglandin f analogues; analogues, prostaglandin f; prostaglandin f analogs; analogs, prostaglandin f;

MeSH annotation : DF: PGF SYN;

Is substance : O;

Details

Origin ID

D011461;

UMLS CUI

C0033562;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- prostaglandin analogues [ATC Code]
MeSH Descriptor(s) used for indexing
- prostaglandins F [MeSH Descriptor]
Record concept(s)
- prostaglandins F, synthetic [MeSH concept]
Related MeSH Supplementary Concept(s)
- 1,1-dihomo-8-ketoprostaglandin F1alpha [MeSH Supplementary Concept]
- 1-(nitrooxymethyl)-2-(nitrooxy)ethyl 7-(3,5-dihydroxy-2-(3-hydroxy-5-phenylpentyl)cyclopentyl)-5-heptenoate [MeSH Supplementary Concept]
- 11-deoxyprostaglandin F1alpha [MeSH Supplementary Concept]
- 15(S)-15-methyl delta(4)-prostaglandin F1alpha [MeSH Supplementary Concept]
- 16,16-dimethyl-delta(4)-prostaglandin F1alpha [MeSH Supplementary Concept]
- 2,3-dinor-6,15-diketo-13,14-dihydroprostaglandin F1alpha [MeSH Supplementary Concept]
- 5,9-epoxy-16-phenoxy-prostaglandin F1 [MeSH Supplementary Concept]
- 5-oxa-17-phenyl-18,19,20-trinor prostaglandin F1 alpha methyl ester [MeSH Supplementary Concept]
- 6-methoxime prostaglandin F1alpha [MeSH Supplementary Concept]
- 7-(3,5-dihydroxy-2-(3-hydroxy-5-phenylpentyl)cyclopentyl)-5-heptenoic acid 6-(nitrooxy)hexyl amide [MeSH Supplementary Concept]
- ACS67 compound [MeSH Supplementary Concept]
- BOL 303259-X [MeSH Supplementary Concept]
- aroxaprostol [MeSH Supplementary Concept]
- delprostenate [MeSH Supplementary Concept]
- fenprostalene [MeSH Supplementary Concept]
- fluprostenol [MeSH Supplementary Concept]
- luprostenol [MeSH Supplementary Concept]
- nocloprost [MeSH Supplementary Concept]
- prostaglandin-ICI 74205 [MeSH Supplementary Concept]
- tiaprost [MeSH Supplementary Concept]
- xalacom [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients